Should methotrexate have any place in the treatment of psoriatic arthritis?
Methotrexate (MTX) is widely used in the treatment of psoriatic arthritis (PsA) despite the evidence base for this being limited. This narrative review summarises the evidence to date of using MTX within different domains of psoriatic disease, including peripheral arthritis, axial disease, dactyliti...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2019
|